SMTL ID : 5vl3.3 (3 other biounits)

CD22 d1-d3 in complex with therapeutic Fab Epratuzumab

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 3.10 Å

Oligo State

hetero-1-1-1-mer

Ligands

1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.1: 4 residues within 4Å: Chain A: L.160, Q.203, F.211, N.214 No protein-ligand interaction detected (PLIP)

1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA.2: 6 residues within 4Å: Chain A: W.24, T.28, L.78, N.84, T.86, Y.151 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:Y.151

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.3: 3 residues within 4Å: Chain A: Y.257 Chain B: Q.65 Chain C: D.4 3 PLIP interactions: 2 interactions with chain C, 1 interactions with chain B Hydrogen bonds: C:D.4, C:D.4, B:Q.65

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ereno-Orbea, J. et al., Molecular basis of human CD22 function and therapeutic targeting. Nat Commun (2017)

Release Date

2017-10-11

Peptides

B-cell receptor CD22: A
Epratuzumab Fab Heavy Chain: B
Epratuzumab Fab Light Chain: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
S

B
C

C
D

B-cell receptor CD22

Epratuzumab Fab Heavy Chain

Epratuzumab Fab Light Chain

Related Entries With Identical Sequence